The role of cytochrome bc1 inhibitors in future tuberculosis treatment regimens.
Aguilar-Pérez C, Lenaerts AJ, Villellas C, Guillemont J, Dallow J, Painter H, Ammerman NC, Hassan A, Golovkine G, Brock L, Sordello S, Chauffour A, Aubry A, Mai TC, Wong S, Clark TG, Nam K, Kim J, Choi J, Crabbe M, Esquivias J, Lounis N, Stoops B, Amssoms K, Bartolome-Nebreda JM, Gruppo V, Robertson GT, Veziris N, Upton AM, Nuermberger EL, Cox V, Ballell L, Baeten B, Koul A, Pym AS, Wall RJ, Lamprecht DA.
Aguilar-Pérez C, et al. Among authors: ammerman nc.
Nat Commun. 2025 Oct 22;16(1):9344. doi: 10.1038/s41467-025-64427-6.
Nat Commun. 2025.
PMID: 41125580
Free PMC article.